Who bought out Cardinal Health?
Hellman & Friedman
DUBLIN, Ohio, March 12, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assumption of certain liabilities and seller’s retention of certain working …
Is Cardinal Health a good buy?
Cardinal Health, Inc. may be undervalued. Its Value Score of A indicates it would be a good pick for value investors. The financial health and growth prospects of CAH, demonstrate its potential to outperform the market. It currently has a Growth Score of C.
Is Cardinal Health a stable company?
On average, employees at Cardinal Health give their company a 3.7 rating out of 5.0 – which is 5% lower than the average rating for all companies on CareerBliss. The happiest Cardinal Health employees are Senior Sales Consultants submitting an average rating of 4.9 and Production Supervisors with a rating of 4.7.
Why is Cardinal Health selling Cordis?
“Our decision to divest Cordis demonstrates our disciplined approach to evaluating our portfolio and focusing our resources in our strategic growth areas where we are an advantaged owner,” said Mike Kaufmann, CEO of Cardinal Health, which estimates that the company brings in $60 million to $70 million in profit …
Is Cardinal Health a Fortune 100 company?
RANK15. Despite bringing in over $160 billion in revenue in 2021, Cardinal Health reported net income of just $611 million for the year.
How many employees does Cardinal Health have?
approximately 44,000 employees
With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world.
Who bought Cordis?
Cardinal Health completes sale of Cordis business to Hellman & Friedman. DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ — Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health’s Cordis business to H&F.
What sector is Cardinal Health?
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products.
Is Cardinal Health a good long term investment?
Summary. Cardinal Health looks like a great long-term value investment current trading at 10.0x forward P/E. The company does a good job returning cash to shareholders through share repurchases of 2.1% annually in addition to the current 3.76% dividend yield.
Is Cardinal Health a dividend king?
As a Dividend Aristocrat, Cardinal Health is likely to continue raising its dividend each year. Moreover, the dividend appears secure, with a projected dividend payout ratio of approximately 34% for fiscal 2022.
Who are competitors of Cardinal Health?
Cardinal Health competitors include AmerisourceBergen, OhioHealth, Henry Schein, McKesson and Carefusion.